JP2023515565A5 - - Google Patents

Info

Publication number
JP2023515565A5
JP2023515565A5 JP2022551040A JP2022551040A JP2023515565A5 JP 2023515565 A5 JP2023515565 A5 JP 2023515565A5 JP 2022551040 A JP2022551040 A JP 2022551040A JP 2022551040 A JP2022551040 A JP 2022551040A JP 2023515565 A5 JP2023515565 A5 JP 2023515565A5
Authority
JP
Japan
Prior art keywords
aryl
heteroaryl
cancer
alkyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022551040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/054559 external-priority patent/WO2021170658A1/en
Publication of JP2023515565A publication Critical patent/JP2023515565A/ja
Publication of JP2023515565A5 publication Critical patent/JP2023515565A5/ja
Priority to JP2026006191A priority Critical patent/JP2026090264A/ja
Pending legal-status Critical Current

Links

JP2022551040A 2020-02-25 2021-02-24 Nr2f6を調節する複素環式化合物 Pending JP2023515565A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026006191A JP2026090264A (ja) 2020-02-25 2026-01-16 Nr2f6を調節する複素環式化合物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062981418P 2020-02-25 2020-02-25
US62/981,418 2020-02-25
US202163139262P 2021-01-19 2021-01-19
US63/139,262 2021-01-19
PCT/EP2021/054559 WO2021170658A1 (en) 2020-02-25 2021-02-24 Heterocyclic compounds for modulating nr2f6

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026006191A Division JP2026090264A (ja) 2020-02-25 2026-01-16 Nr2f6を調節する複素環式化合物

Publications (2)

Publication Number Publication Date
JP2023515565A JP2023515565A (ja) 2023-04-13
JP2023515565A5 true JP2023515565A5 (cg-RX-API-DMAC10.html) 2024-02-29

Family

ID=74797908

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022551040A Pending JP2023515565A (ja) 2020-02-25 2021-02-24 Nr2f6を調節する複素環式化合物
JP2026006191A Pending JP2026090264A (ja) 2020-02-25 2026-01-16 Nr2f6を調節する複素環式化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2026006191A Pending JP2026090264A (ja) 2020-02-25 2026-01-16 Nr2f6を調節する複素環式化合物

Country Status (12)

Country Link
US (1) US20220213061A9 (cg-RX-API-DMAC10.html)
EP (1) EP4110758A1 (cg-RX-API-DMAC10.html)
JP (2) JP2023515565A (cg-RX-API-DMAC10.html)
KR (1) KR20220158228A (cg-RX-API-DMAC10.html)
CN (2) CN118878514A (cg-RX-API-DMAC10.html)
AU (1) AU2021226974A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022016941A2 (cg-RX-API-DMAC10.html)
CA (1) CA3167785A1 (cg-RX-API-DMAC10.html)
IL (1) IL295456B2 (cg-RX-API-DMAC10.html)
MX (1) MX2022010456A (cg-RX-API-DMAC10.html)
TW (1) TW202140447A (cg-RX-API-DMAC10.html)
WO (1) WO2021170658A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023042914A1 (en) * 2021-09-17 2023-03-23 Otsuka Pharmaceutical Co., Ltd. Pyrrolidine compounds as histone deacetylase inhibitors
WO2025106383A1 (en) * 2023-11-17 2025-05-22 Merck Sharp & Dohme Llc Pyrrolidinyl derivatives useful as hcn1/hcn 2 modulators
WO2025248483A1 (ko) * 2024-05-30 2025-12-04 삼진제약주식회사 Nr2f6 억제제 및 이의 용도
WO2026132784A2 (en) * 2024-12-19 2026-06-25 Storm Therapeutics Ltd Inhibitory compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153851B2 (en) * 2002-03-18 2006-12-26 Kyorin Pharmaceutical Co., Ltd. 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium
WO2005016000A1 (en) * 2003-08-05 2005-02-24 Avalon Pharmaceuticals Derivatives of cyclic quinone and uses thereof
US7138423B2 (en) * 2004-07-20 2006-11-21 Bristol-Myers Squibb Company Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
CA2631221C (en) * 2005-12-01 2014-06-03 F. Hoffmann-La Roche Ag Serotonin transporter (sert) inhibitors
JP2011507850A (ja) * 2007-12-21 2011-03-10 ザ スクリプス リサーチ インスティチュート Rhoキナーゼインヒビターとしてのアニリドおよびアナログ
US8450344B2 (en) * 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
WO2010024903A1 (en) * 2008-08-29 2010-03-04 Yangbo Feng BENZO[d]OXAZOLES AND BENZO[d]THIAZOLES AS KINASE INHIBITORS
WO2010059922A1 (en) * 2008-11-21 2010-05-27 Ligand Pharmaceuticals Incorporated Pyrrolidine carboxamide compounds
US9617214B2 (en) * 2013-11-08 2017-04-11 The Translational Genomics Research Institute Compounds for cognitive enhancement and methods of use thereof
US11324719B2 (en) * 2016-07-18 2022-05-10 Kcl Therapeutics, Inc. Small molecule agonists and antagonists of NR2F6 activity in humans
US10472351B2 (en) * 2016-07-18 2019-11-12 Zander Therapeutics, Inc. Small molecule agonists and antagonists of NR2F6 activity in animals
WO2018024188A1 (zh) * 2016-08-02 2018-02-08 上海迪诺医药科技有限公司 多环化合物、其制备方法、药物组合物及应用
CN110520129A (zh) * 2017-02-17 2019-11-29 特维娜有限公司 含有5元氮杂杂环的δ阿片受体调节化合物及其使用和制备方法
CN110776521A (zh) * 2019-10-24 2020-02-11 秦源生物医药科技(上海)有限公司 一种1,2,4-三唑-1,3,4-噻二唑类化合物及其应用

Similar Documents

Publication Publication Date Title
JP2024178191A5 (cg-RX-API-DMAC10.html)
CN113766954A (zh) 喜树碱衍生物
JP2024545233A5 (cg-RX-API-DMAC10.html)
CN112300180B (zh) 一种irak4激酶抑制剂及其制备方法
WO2023217227A1 (zh) 喜树碱类衍生物及配体-药物偶联物
ES3062921T3 (en) Preparation method for novel rho-related protein kinase inhibitor and intermediate in preparation method
JP2025503322A5 (cg-RX-API-DMAC10.html)
WO2017165851A1 (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
JP2021529814A (ja) 化学化合物
WO2024020536A1 (en) Hexacyclic topoisomerase inhibitors having cytotoxic activity on cancer cells
EP3908579A1 (en) Dihydroorotate dehydrogenase inhibitors
JP2023542065A5 (cg-RX-API-DMAC10.html)
IL273387B2 (en) Thylanstatin analogs
JP2024523422A5 (cg-RX-API-DMAC10.html)
JP2022500476A (ja) 環状ジヌクレオチド類似体、その医薬組成物及び使用
JP2026513781A (ja) カンプトテシン誘導体、医薬組成物及びその製造方法と応用
TW202535885A (zh) 配體-藥物偶聯物、偶聯連接子及其用途
CN105164138B (zh) 新吗啉基蒽环类抗生素衍生物
IL295456A (en) Heterocyclic compounds for modulating nr2f6
CN120936388A (zh) 抗cdh6抗体药物偶联物及其用途
AU2020338985A1 (en) Substituted urea dihydroorotate dehydrogenase inhibitors
EP1718340B1 (en) New effector conjugates, process for their production and their pharmaceutical use
WO2024250984A1 (zh) 一种抗体药物偶联物,及其药物组合物、制备和用途
CN111662295A (zh) 一种irak4激酶抑制剂及其制备方法
RU2025126517A (ru) Производное камптотецина и фармацевтическая композиция, способ их получения и их применение